✦ LIBER ✦

6594 POSTER First-line bevacizumab in combination with chemotherapy in the treatment of patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC): an open-label safety study (MO19390)

✍ Scribed by Crinó, L.; Dansin, E.; Garrido Lopez, P.; Griesinger, F.; Laskin, J.; Pavlakis, N.; Thatcher, N.; Tsai, C.M.; Stroyakovskiy, D.; Su, W.C.

Book ID: 123471332
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 57 KB
Volume: 5
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(07)71422-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

9170 Safety and efficacy of first-line b

9170 Safety and efficacy of first-line bevacizumab (Bv) plus chemotherapy in elderly patients (pts) with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC): SAiL (MO19390)

✍ Garrido, P.; Thatcher, N.; Crino, L.; Dansin, E.; Laskin, J.; Pavlakis, N.; Tsai 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

9168 Safety and efficacy of first-line b

9168 Safety and efficacy of first-line bevacizumab-based therapy in advanced non-small cell lung cancer (NSCLC): results of the SAiL study (MO19390)

✍ Dansin, E.; Tsai, C.M.; Pavlakis, N.; Laskin, J.; Griesinger, F.; Garrido, P.; C 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

A phase II study of erlotinib in combina

A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancer

✍ Ciuleanu, T.; Tsai, C.-M.; Tsao, C.-J.; Milanowski, J.; Amoroso, D.; Heo, D.S.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 718 KB

Erlotinib alone or with bevacizumab as f

Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre, phase 2 study

✍ Seto, Takashi; Kato, Terufumi; Nishio, Makoto; Goto, Koichi; Atagi, Shinji; Hoso 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 398 KB

9149 Phase II study of bevacizumab in co

9149 Phase II study of bevacizumab in combination with cisplatin and docetaxel as first line treatment of patients (p) with metastatic non squamous non-small-cell lung cancer (NSCLC)

✍ Ferrer, N.; Cobo, M.; Paredes, A.; Méndez, M.; Muñoz-Langa, J.; Rueda, A.; de Mo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Randomized phase II study of first-line

Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancer

✍ Niho, Seiji; Kunitoh, Hideo; Nokihara, Hiroshi; Horai, Takeshi; Ichinose, Yukito 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 408 KB